Literature DB >> 19228224

Clinical guidelines for overactive bladder.

Osamu Yamaguchi1, Osamu Nishizawa, Masayuki Takeda, Osamu Yokoyama, Yukio Homma, Hidehiro Kakizaki, Kenji Obara, Momokazu Gotoh, Yasuhiko Igawa, Naarihito Seki, Masaki Yoshida.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19228224     DOI: 10.1111/j.1442-2042.2008.02177.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


× No keyword cloud information.
  38 in total

1.  [Urodynamic classification of male patients with symptoms of overactive bladder and the outcome classification].

Authors:  T Wang; K X Xu; W Y Zhang; H Hu; X W Zhang; H R Wang; X H Liu; J W Chen; X P Zhang
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-12-18

2.  Impact of Loss of Work Productivity in Patients with Overactive Bladder Treated with Antimuscarinics in Spain: Study in Routine Clinical Practice Conditions.

Authors:  Antoni Sicras-Mainar; Ruth Navarro-Artieda; Amador Ruiz-Torrejón; Marc Sáez-Zafra; Gabriel Coll-de Tuero
Journal:  Clin Drug Investig       Date:  2015-12       Impact factor: 2.859

3.  The impact of abdominal aortic calcification and visceral fat obesity on lower urinary tract symptoms in patients with benign prostatic hyperplasia.

Authors:  Tadasu Motoya; Seiji Matsumoto; Satoshi Yamaguchi; Naoki Wada; Atsushi Numata; Hiroaki Osanai; Hidehiro Kakizaki
Journal:  Int Urol Nephrol       Date:  2014-06-08       Impact factor: 2.370

Review 4.  Postmenopausal hormone therapy: an Endocrine Society scientific statement.

Authors:  Richard J Santen; D Craig Allred; Stacy P Ardoin; David F Archer; Norman Boyd; Glenn D Braunstein; Henry G Burger; Graham A Colditz; Susan R Davis; Marco Gambacciani; Barbara A Gower; Victor W Henderson; Wael N Jarjour; Richard H Karas; Michael Kleerekoper; Roger A Lobo; JoAnn E Manson; Jo Marsden; Kathryn A Martin; Lisa Martin; JoAnn V Pinkerton; David R Rubinow; Helena Teede; Diane M Thiboutot; Wulf H Utian
Journal:  J Clin Endocrinol Metab       Date:  2010-06-21       Impact factor: 5.958

5.  Efficacy and safety of Baweidihuang-wan in women with overactive bladder: a randomized, double blind, placebo controlled trial.

Authors:  Dongil Kim; Changmin Choi; Insuk Ahn; Ikhan Ryu; Minsun Choi; Younsuk Lee; Myeong Soo Lee
Journal:  Int J Clin Exp Med       Date:  2014-09-15

Review 6.  Flavoxate in urogynecology: an old drug revisited.

Authors:  Murat Zor; Emin Aydur; Roger Roman Dmochowski
Journal:  Int Urogynecol J       Date:  2014-12-06       Impact factor: 2.894

Review 7.  Propiverine: a review of its use in the treatment of adults and children with overactive bladder associated with idiopathic or neurogenic detrusor overactivity, and in men with lower urinary tract symptoms.

Authors:  Kate McKeage
Journal:  Clin Drug Investig       Date:  2013-01       Impact factor: 2.859

Review 8.  Overactive Bladder Syndrome: Evaluation and Management.

Authors:  Elad Leron; Adi Y Weintraub; Salvatore A Mastrolia; Polina Schwarzman
Journal:  Curr Urol       Date:  2018-02-20

Review 9.  OnabotulinumtoxinA Treatment for Overactive Bladder in the Elderly: Practical Points and Future Prospects.

Authors:  Hann-Chorng Kuo
Journal:  Drugs Aging       Date:  2016-01       Impact factor: 3.923

10.  Association between overactive bladder and pelvic organ mobility as evaluated by dynamic magnetic resonance imaging.

Authors:  Kurenai Kinno; Noritoshi Sekido; Yasuharu Takeuchi; Yoshitomo Sawada; Shoutarou Watanabe; Yasukuni Yoshimura
Journal:  Sci Rep       Date:  2021-07-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.